Cryopreservation of human blood products

Transfusion and Apheresis Science

Volumn 34, Issue 3, 2006, Pages 271-287

  Valeri, C Robert ^a   Ragno, Gina ^a  

^a Naval Blood Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; CRYOPRESERVATION; ERYTHROCYTE; HEMORRHAGIC SHOCK; HUMAN; LEUKAPHERESIS; LOW TEMPERATURE; MONONUCLEAR CELL; PLURIPOTENT STEM CELL; RADIATION INJURY; SOLDIER; THAWING; THROMBOCYTE;

BLOOD PRESERVATION; CRYOPRESERVATION; HEMATOPOIETIC STEM CELLS; HUMANS; MILITARY MEDICINE; PLURIPOTENT STEM CELLS; RADIATION INJURIES;

EID: 33747365647     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2005.11.010     Document Type: Article

References (123)

1. Smith A.U. Prevention of haemolysis during freezing and thawing of red blood cells. Lancet 2 (1950) 910-911
2. Valeri C.R. Blood banking and the use of frozen blood products (1976), Chemical Rubber Co, Boca Raton
3. Valeri C.R., Ragno G., and Pivacek L.E. Frozen platelets. In: Seghatchian J., Snyder E.L., and Krailadsiri P. (Eds). Platelet therapy: current status and future trends (2000), Elsevier Science, Clinical Medicine, Amsterdam 105-130
4. Schiffer C.A., Aisner J., and Wiernik P.H. Frozen autologous platelet transfusion for patients with leukemia. N Engl J Med 299 (1978) 7-12
5. Daly P.A., Schiffer C.A., Aisner J., and Wiernik P.H. Successful transfusion of platelets cryopreserved for more than 3 years. Blood 54 (1979) 1023-1027
6. Melaragno A.J., Carciero R., Feingold H., Talarico L., Weintraub L., and Valeri C.R. Cryopreservation of human platelets using 6% dimethyl sulfoxide and storage at -80 °C. Effect of 2 years of frozen storage at -80 °C and transportation in dry ice. Vox Sang 49 (1985) 245-258
7. Valeri C.R., Gennaoui A., and Ragno G. The effect of storage of fresh frozen plasma at -80 °C for as long as 14 years on plasma clotting proteins. Transfusion 45 (2005) 1829-1830
8. Valeri C.R., Gennaoui A., and Ragno G. The effect of storage of fresh frozen plasma at -80 °C for 2 years following storage at -20 °C for 15 months. Transfusion 45 (2005) SP141 73 A
9. McCallum C.J., Peake I.R., Newcombe R.G., and Bloom A.L. Factor VIII levels and blood group antigens. Thromb Haemostas 50 (1983) 757
10. Valeri C.R., Pivacek L.E., Cassidy G.P., and Ragno G. In vitro and in vivo measurements of human RBCs frozen with glycerol and subjected to various storage temperatures before deglycerolization and storage at 4 °C for 3 days. Transfusion 41 (2001) 401-405
11. Valeri C.R., Sims K.L., Bates J.F., Reichman D., Lindberg J.R., and Wilson A.C. An integrated liquid-frozen blood banking system. Vox Sang 45 (1983) 25-39
12. Valeri C.R., Ragno G., Pivacek L.E., Cassidy G.P., Srey R., Hansson-Wicher M., et al. An experiment with glycerol-frozen red blood cells stored at -80 °C for up to 37 years. Vox Sang 79 (2000) 168-174
13. Valeri C.R., and Pivacek L.E. Effects of the temperature, the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells. Transfusion 36 (1996) 303-308
14. Tullis J.L., Ketchel M.M., Pyle H.M., Pennell R.B., Gibson II J.G., Tinch R.J., et al. Studies on the in vivo survival of glycerolized and frozen human red blood cells. JAMA 168 (1958) 399-404
15. Pert J.H., Schork P.K., and Moore R. A new method of low-temperature blood preservation using liquid nitrogen and a glycerol-sucrose additive. Clin Res 11 (1963) 197
16. Rowe A.W., Eyster E., and Kellner A. Liquid nitrogen preservation of red blood cells for transfusion: a low glycerol-rapid freeze procedure. Cryobiology 5 (1968) 119-128
17. Krijnen H.W., de Wit J.J., Kuivenhoven A.C.J., Loos J.A., and Prins H.K. Glycerol treated human red cells frozen with liquid nitrogen. Vox Sang 9 (1964) 559-572
18. Rubinstein P., Dobrila L., Rosenfield R.E., Adamson J.W., Migliaccio G., Migliaccio A.R., et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92 (1995) 10119-10122
19. Broxmeyer H.E., Srour E.F., Hangoc G., Cooper S., Anderson S.A., and Bodine D.M. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. PNAS 100 (2003) 645-650
20. Valeri C.R., Lane J., Srey R., and Ragno G. Incidence of breakage of human RBCs frozen with 40 percent wt/vol glycerol using two different methods for storage at -80 °C. Transfusion 43 3 (2003) 411-414
21. Valeri C.R., Srey R., Lane J.P., and Ragno G. Effect of WBC reduction and storage temperature on PLTS frozen with 6 percent DMSO for as long as 3 years. Transfusion 43 8 (2003) 1162-1167
22. Valeri C.R., and Ragno G. Breakage rate for red blood cells frozen with 40% (wt/vol) glycerol in 800 mL polyvinylchloride plastic bags stored in rigid cardboard boxes at -80 °C. Transfusion 45 (2005) 822-823
23. Valeri C.R., and Henderson M.E. Recent difficulties with frozen glycerolized blood. JAMA 188 (1964) 1125-1131
24. Huggins C.E. Prevention of hemolysis of large volumes of red blood cells slowly frozen and thawed in the presence of dimethylsulfoxide. Transfusion 3 (1963) 483-493
25. Huggins C.E. Frozen blood: theory and practice. JAMA 193 (1965) 941-944
26. Moss G.S., Valeri C.R., and Brodine C.E. Clinical experience with the use of frozen blood in combat casualties. NEJM 278 (1968) 747-752
27. Meryman H.T., and Hornblower M. A method for freezing and washing red blood cells using a high glycerol concentration. Transfusion 12 (1972) 145-156
28. Valeri C.R. Simplification of the methods for adding and removing glycerol during freeze preservation of human red blood cells with the high or low glycerol methods: biochemical modification prior to freezing. Transfusion 15 (1975) 195-218
29. Valeri C.R., Valeri D.A., Anastasi J., Vecchione J.J., Dennis R.C., and Emerson C.P. Freezing in the primary polyvinylchloride plastic collection bag: a new system for preparing and freezing nonrejuvenated and rejuvenated red blood cells. Transfusion 21 (1981) 138-140
30. Valeri C.R., Ragno G., Pivacek L., and O'Neill E.M. In vivo survival of apheresis RBCs frozen with 40 percent (wt/vol) glycerol, deglycerolized in the ACP215 and stored at 4 °C in AS-3 for up to 21 days. Transfusion 41 (2001) 928-932
31. Valeri C.R., Ragno G., Pivacek L.E., Srey R., Hess J.R., Lippert L.E., et al. A multicenter study of in vitro and in vivo values in human red blood cells frozen with 40 percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4 °C in AS-3: assessment of RBC processing in the ACP215. Transfusion 41 7 (2001) 933-939
32. Moore G.L., Hess J.R., and Ledford M.E. In vivo viability studies of two additive solutions in the postthaw preservation of red cells held for 3 weeks at 4 °C. Transfusion 33 (1993) 709-712
33. Lelkens C.C.M., Noorman F., Koning J.G., Truijens-de Lange R., Stekkinger P.S., Bakker J.C., et al. Stability after thawing of RBCS frozen with the high- and low-glycerol method. Transfusion 43 (2003) 157-164
34. Valeri C.R., Pivacek L.E., Gray A.D., Cassidy G.P., Dennis R.C., Melaragno A.J., et al. The safety and therapeutic effectiveness of human red cells frozen with 40% to 45% (W/V) glycerol and stored at -80 °C for as long as 21 years. Transfusion 29 (1989) 429-437
35. Valeri C.R., Srey R., Tilahun D., and Ragno G. The in vitro quality of red blood cells frozen with 40% W/V glycerol at -80 °C for 14 years, deglycerolized with the Haemonetics ACP215 and stored at 4 °C in additive solution-1 or additive solution-3 for up to 3 weeks. Transfusion 44 (2004) 990-995
36. Bandarenko N., Hay S.N., Holmberg J., Whitley P., Taylor H.L., Moroff G., et al. Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system. Transfusion 44 (2004) 1656-1662
37. Valeri C.R., Ragno G., van Houten P., Rose L., Rose M., Egozy Y., et al. Automation of glycerolization of RBC using the high separation bowl in the Haemonetics ACP215 instrument. Transfusion 45 (2005) 1621-1627
38. Valeri C.R., and Zaroulis C.G. Rejuvenation and freezing of outdated stored human red cells. N Engl J Med 287 (1972) 1307-1313
39. Valeri C.R. Use of rejuvenation solutions in red blood cell preservation. Crit Rev Clin Lab Sci 17 (1982) 299-374
40. Valeri C.R., Valeri D.A., Dennis R.C., Vecchione J.J., and Emerson C.P. Biomedical modification and freeze-preservation of red blood cells. A new method. Crit Care Med 7 (1979) 439-447
41. Valeri C.R., and Altschule M.D. Hypovolemic anemia of trauma: the missing blood syndrome (1981), Chemical Rubber Company, Boca Raton, FL
42. Valeri C.R., and Fortier N.L. Red-cell mass deficits and erythrocyte 2,3 DPG levels. Forsvarsmedicin 5 (1969) 212-218
43. Valeri C.R., and Fortier N.L. Red-cell 2,3 diphosphoglycerate and creatine levels in patients with red-cell mass deficits or with cardiopulmonary insufficiency. N Engl J Med 81 (1969) 1452-1455
44. Valeri C.R., Zaroulis C.G., Vecchione J.J., Valeri D.A., Anastasi J., Pivacek L.E., et al. Therapeutic effectiveness and safety of outdated human red blood cells rejuvenated to restore oxygen transport function to normal, frozen for 3 to 4 years at -80 °C, washed and stored at 4 °C for 24 h prior to rapid infusion. Transfusion 20 (1980) 159-170
45. Valeri C.R., Zaroulis C.G., Vecchione J.J., Valeri D.A., Anastasi J., Pivacek L.E., et al. Therapeutic effectiveness and safety of outdated human red blood cells rejuvenated to improve oxygen transport function, frozen for about 1.5 years at -80 °C, washed and stored at 4 °C for 24 h prior to rapid infusion. Transfusion 20 (1980) 263-276
46. Valeri C.R., Vecchione J.J., Pivacek L.E., Lowrie G.B., Austin R.M., and Emerson C.P. Viability and function of outdated human red blood cells after biochemical modification to improve oxygen transport function, freezing, thawing, washing, postthaw storage at 4 °C, perfusion in vitro through a bubble oxygenator and autotransfusion. Transfusion 20 (1980) 39-46
47. Valeri C.R., Pivacek L.E., Cassidy G.P., and Ragno G. The survival, function and hemolysis of human RBCs stored at 4 °C in additive solution (AS-1, AS-3, or AS-5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4 °C in sodium chloride and glucose solution for 24 h. Transfusion 40 (2000) 1341-1345
48. Lockwood W.B., Hudgens R.W., Szymanski I.O., Teno R.A., and Gray A.D. Effects of rejuvenation and frozen storage on 42-day-old AS-3 RBCs. Transfusion 43 (2003) 1527-1532
49. Alter H.J., Tabor E., Meryman H.T., Hoofnagle J.H., Kahn R.A., Holland P.V., et al. Transmission of hepatitis B virus infection by transfusion of frozen-deglycerolized red blood cells. N Engl J Med 298 (1978) 637-642
50. Haugen R.K. Hepatitis after the transfusion of frozen red cells and washed red cells. N Engl J Med 301 (1979) 393-395
51. Opelz G., Sangar D.P.S., Mickey M.R., and Terasaki P.I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5 (1973) 253-259
52. Opelz G., and Terasaki P.I. Poor kidney transplant survival in recipients with frozen blood transfusions or no transfusions. Lancet 2 (1974) 696-698
53. Opelz G., and Terasaki P.I. Prolongation effect of blood transfusions on kidney graft survival. Transplantation 22 (1976) 380-383
54. Crowley J.P., Skrabut E.M., and Valeri C.R. Immunocompetent lymphocytes in previously frozen washed red cells. Vox Sang 26 (1974) 513-517
55. Valeri C.R., Pivacek L.E., Cassidy G.P., and Ragno G. In vitro and in vivo measurements of gamma-radiated, frozen, glycerolized RBCs. Transfusion 41 (2001) 545-549
56. Popovsky M.A., Abel M.D., and Moore S.B. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 128 (1983) 185-189
57. Holme S., Rose M., Holmberg J., and Popovsky M. An automated method for washing red cells in a closed system. Transfusion 41 (2001) 36 S
58. Goldman M., Webert K.E., Arnold D.M., Freedman J., Hannon J., and Blajchman M.A. TRALI Consensus Panel. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 18 (2005) 2-31
59. Petersen L.R., Satten G.A., Dodd R., Busch M., Kleinman S., Grindon A., et al. Duration of time from onset of human immunodeficiency virus type I: infectiousness to development of detectable antibody. Transfusion 34 (1994) 283-289
60. Handin R.I., and Valeri C.R. Improved viability of previously frozen platelets. Blood 40 (1972) 509-513
61. Valeri C.R., Feingold H., and Marchionni L.D. A simple method for freezing human platelets using 6% dimethylsulfoxide and storage at -80 °C. Blood 43 (1974) 131-136
62. Valeri C.R. Hemostatic effectiveness of liquid preserved and previously frozen platelets. N Engl J Med 290 (1974) 353-358
63. Zaroulis C.G., Spector J.I., Emerson C.P., and Valeri C.R. Therapeutic effectiveness of previously frozen washed human platelets. Transfusion 19 (1979) 371-379
64. Valeri C.R. The current state of platelet and granulocyte cryopreservation. Crit Rev Clin Lab Sci 14 (1981) 21-74
65. Valeri C.R., MacGregor H., Giorgio A., and Ragno G. Circulation and hemostatic function of autologous fresh, liquid preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy. Transfusion 42 (2002) 1206-1216
66. Khuri S.F., Healey N., MacGregor H., Barnard M.R., Szymanski I.O., Birjuniuk V., et al. Comparison of the effects of transfusions of cryopreserved and liquid preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 117 (1999) 172-184
67. Valeri C.R., MacGregor H., and Ragno G. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid preserved and cryopreserved human platelets: effects of agonists, pH, and plasma and saline resuspension. Transfusion 45 (2005) 596-603
68. Valeri C.R., Feingold H., and Marchionni L.D. The relation between response to hypotonic stress and the 51Cr recovery in vivo of preserved platelets. Transfusion 14 (1974) 331-337
69. Spector J.I., Yarmala J.A., Marchionni L.D., Emerson C.P., and Valeri C.R. Viability and function of platelets frozen at 2 to 3 °C per minute with 4 or 5 percent DMSO and stored at -80 °C for 8 months. Transfusion 17 (1977) 8-15
70. Vecchione J.J., Melaragno A.J., Hollander A., Defina S., Emerson C.P., and Valeri C.R. Circulation and function of human platelets isolated from units of CPDA-1, CPDA-2, and CPDA-3 anticoagulated blood and frozen with DMSO. Transfusion 22 (1982) 206-209
71. Valeri C.R., Ragno G., and Khuri S. Freezing human platelets using 6% DMSO with removal of the supernatant solution prior to freezing and storage at -80 °C without post-thaw processing. Transfusion 45 (2005) 1890-1898
72. Barnard M.R., MacGregor H., Ragno G., Pivacek L.E., Khuri S.F., Michelson A.D., and Valeri C.R. Fresh liquid-preserved, and cryopreserved platelets: adhesive surface receptors and membrane procoagulant activity. Transfusion 39 (1999) 880-888
73. Valeri C.R., MacGregor H., Barnard M.R., Summaria L., Michelson A.D., and Ragno G. Survival of baboon biotin-X-NHS and 111In-oxine-labeled autologous fresh and lyophilized reconstituted platelets. Vox Sang 88 (2005) 122-129
74. Hoffmeister K.M., Felbinger T.W., Falet H., Denis C.V., Bergmeier W., Mayadas T.N., et al. The clearance mechanism of chilled blood platelets. Cell 112 (2003) 87-97
75. Hoffmeister K.M., Josefsson E.C., Isaac N.A., Clausen H., Hartwig J.H., and Stossel T.P. Glycosylation restores survival of chilled blood platelets. Science 301 (2003) 1531-1534
76. Bergmeier W., Burger P.C., Piffath C.L., Hoffmeister K.M., Hartwig J.H., Nieswandt B., et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 102 12 (2003) 4229-4235
77. Leytin V., Allen D.J., Gwozdz A., Garvey B., and Freedman J. Role of platelet surface glycoprotein Ibα and P-selectin in the clearance of transfused platelet concentrates. Transfusion 44 (2004) 1487-1495
78. Xiao H.Y., Matsubayashi H., Bonderman D.P., Bonderman P.W., Reid T., Miraglia C.C., et al. Generation of annexin V-positive platelets and shedding of microparticles with stimulus dependent procoagulant activity during storage of platelets at 4 °C. Transfusion 40 (2000) 420-427
79. Srivastava A., Wang J., Majumder B., Rezaie A.R., Stenflo J., Esmon C.T., et al. Localization of phosphatidylserine binding sites to structural domains of factorXa. J Biol Chem 277 (2002) 1855-1863
80. Wu J.R., Zhou C., Majumder R., Powers D.D., Weinreb G., and Lentz B.R. Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor Xa in the absence of factor Va and in the absence and presence of membranes. Biochemistry 43 (2002) 935-949
81. Li M.O., Sarkisian M.R., Mehal W.Z., Rakic P., and Flavell R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302 (2003) 1560-1563
82. George J.N., Pickett E.B., Saucerman S., McEver R.P., Kunicki T.J., Kieffer N., et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 78 (1986) 340-348
83. Owens M.R. The role of platelet microparticles in hemostasis. Trans Med Rev 8 (1994) 37-44
84. Valeri C.R. Cryopreservation of human platelets and bone marrow and peripheral blood totipotential mononuclear stem cells. Ann NY Acad Sci 459 (1985) 353-366
85. Valeri C.R. Blood and bone marrow products in the treatment of radiation injury. In: Browne D., et al. (Ed). Treatment of radiation injuries (1990), Plenum Press, New York, NY 19-27
86. Hunt S.M., Lionetti F.J., and Valeri C.R. Isolation and cryopreservation of monocytes from plateletapheresis cellular residues. Transfusion 23 (1983) 387-390
87. Carciero R., and Valeri C.R. Isolation of mononuclear leukocytes in a plastic bag system using ficoll-hypaque. Vox Sang 49 (1985) 373-380
88. Rowley S.D. Hematopoietic stem cell processing and cryopreservation. J Clin Apheresis 7 (1992) 132-134
89. Fraser J.K., Cairo M.S., Wagner E.L., McCurdy P.R., DeRisi M.F., Clarkson B.D., et al. Cord Blood Transportation Study (COBLT): cord blood bank standard operating procedures. J Hematother 7 (1998) 521-561
90. Stiff P.J., Murgo A.J., and Zaroulis C.G. Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. Cryobiology 20 (1983) 17-24
91. Stiff P.J., Koester A.R., Weidner M.K., Dvorak K., and Fisher R.I. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled rate freezing. Blood 70 (1987) 974-978
92. Halle P., Tournilhac O., Knopinska-Posluszny W., Kanold J., Gembara P.B., Boiret N., et al. Uncontrolled-rate freezing and storage at -80 °C, with only 3.5 percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 41 (2001) 667-673
93. Lemarie C., Calmels B., Malenfant C., Arneodo V., Blaise D., Viret F., et al. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device : CytoMate. Transfusion 43 (2005) 737-742
94. Rodriguez L., Velasco B., Garcia J., and Martin-Henao G.A. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion 45 (2005) 1391-1397
95. Dhodapkar M., Goldberg S.L., Tefferi A., and Gertz M.A. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 45 (1994) 187-188
96. Zambelli A., Poggi G., Da Prada G.A., Pedrazzoli P., Cuomo A., Miotti D., et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 28 (1998) 4705-4708
97. Martino M., Morabito F., Messina G., Irrera G., Pucci G., and Iacopino P. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologia 81 (1996) 59-61
98. Benekli M., Anderson B., Wentling D., Bernstein S., Czuczman M., and McCarthy P. Severe respiratory depression after dimethylsulfoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplantation 25 (2000) 1299-1301
99. Hoyt R., Szer J., and Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 24 (2000) 1285-1287
100. Higman M.A., Port J.D., Beauchamp Jr. N.J., and Chen A.R. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 26 (2000) 797-800
101. Zenahausern R., Tobler A., Leoncini L., Hess O.M., and Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 79 (2000) 523-526
102. Davis J.M., Rowley S.D., Braine H.G., Piantadosi S., and Santos G.W. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 75 (1990) 781-786
103. Stroncek D.F., Fautsch S.K., Lasky L.C., Hard D.D., Ramsay N.K., and McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 31 (1991) 521-526
104. Lopez-Jiminez J., Cervero C., Munoz A., Hernandez-Madrid A., Fernandez Pineada J., Garcia Larna J., et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts : results of a controlled study. Bone Marrow Transplant 13 (1994) 789-793
105. Alessandrino P., Bernesconi P., Caldera D., Colombo A., Bonfichi M., Malcovati L., et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion : analysis of 126 cases. Bone Marrow Transplant 23 (1999) 533-537
106. Hoyt R., Szer J., and Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 23 (2000) 1285-1287
107. Ali B.H. Dimethyl sulfoxide: Recent pharmacological and toxicological research. Veterinary Human Toxicol 43 (2001) 228-231
108. Hubel A. Cryopreservation of HPCs for clinical use. Transfusion 41 (2001) 579-580
109. Hubel A., Cariquist D., Clay M., and McCullough J. Liquid storage, shipment and cryopreservation of cord blood. Transfusion 44 (2004) 518-525
110. McCullough J., McKenna D., Kadidlo Schierman T., and Wagner J. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion 45 (2005) 832-841
111. Snyder E.L., and Haley N.R. Cord blood units for adult transplantation: child's play no longer. Transfusion 45 (2005) 829-831
112. Wall D.A. Issues in the quality of umbilical cord blood stem cells for transplantation: challenges in cord blood banking quality management. Transfusion 45 (2005) 826-828
113. Abrahamsen J.F., Bakken A.M., and Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 42 (2003) 1573-1580
114. Rowley S.D., Feng Z., Chen L., Holmberg L., Heimfeld S., MacLeod B., et al. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 31 (2003) 1043-1051
115. Montanari M., Capelli D., Poloni A., Massidda D., Brunori M., Spitaleri L., et al. Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled rate freezing and uncontrolled-rate freezing at -80 °C. Transfusion 43 (2003) 42-49
116. Hernandez-Navarro F., Ojeda E., Arrieta R., Rios-Rull P., Garcia-Bustos J., Quevedo E., et al. Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases. Bone Marrow Transplant 21 (1998) 511-517
117. Cilloni D., Garau D., Regazzi F., et al. Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing. Bone Marrow Transplant 23 (1999) 497-503
118. Almici C., Ferrerni P., Lanfranchi A., Ferrari E., Verardi R., Martini M., et al. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment of sparing primitive and committed hematopoietic progenitors. Haematologica 88 (2003) 1390-1395
119. Moroff G., Seetharaman S., Kurtz J.W., Greco N.J., Mullen M.D., Lane T.A., et al. Retention of cellular properties of PBPCs following liquid storage and cryopreservation. Transfusion 44 (2004) 245-252
120. Encabo A., Mateu E., Carbonell-Uberos F., and Minana M.D. CD34+CD38- is a good predictive marker of cloning ability and expansion potential of CD34+ cord blood cells. Transfusion 43 (2003) 383-389
121. Keeney M., Chin-Yee I., Weir K., Popma J., Nayar R., and Sutherland D.R. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 34 (1998) 61-70
122. Zubair A.C., Zahrieh D., Daley H., Schott D., Gribben J.G., Alyea E.P., et al. Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy. Transfusion 44 (2004) 253-261
123. Erker C.G., Steins M.B., Fischer R.-J., Kienast J., Berdel W.E., Sibrowski W., et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 45 (2005) 1382-1390